Beyond guidelines: what do I need to know when dealing with fungal diagnostics?

Area of Science:

• Medical Mycology
• Clinical Diagnostics
• Infectious Diseases

Background:

• Diagnosing invasive fungal infections (IFIs) is complex due to variable test performance, overlapping fungal appearances, and patient-specific factors like immune status.
• Factors such as host immune status, specimen type, prior antifungal exposure, and cross-reactivity can significantly impact diagnostic accuracy and interpretation.
• Distinguishing colonization from true invasion is critical for appropriate treatment decisions.

Purpose of the Study:

• To provide practical, 'beyond-guideline' insights for reliable IFI diagnosis.
• To outline a context-driven diagnostic approach complementing existing recommendations.
• To improve the accuracy and timeliness of IFI diagnosis.

Main Methods:

• Narrative synthesis of recent (2020-2025) PubMed-indexed literature on fungal diagnostics.
• Inclusion of current global guidelines from ECMM, ISHAM, and ASM.
• Review of landmark papers and comparison of traditional and emerging diagnostic modalities.

Main Results:

• Host immune status, specimen choice, and prior antifungal use critically influence diagnostic test performance.
• Cross-reactivity and mixed infections can complicate interpretation of fungal markers.
• Comparison of microscopy, culture, antigen assays, PCR, and next-generation sequencing across major fungal pathogens is presented.

Conclusions:

• A layered, context-aware diagnostic approach using multiple modalities improves time-to-diagnosis and reduces errors.
• Integrating these strategies into routine practice and guidelines enhances IFI outcomes and antifungal stewardship.
• This approach facilitates earlier, targeted antifungal therapy.